EAGLE HARBOR ASSET MANAGEMENT INC /ADV’s AbbVie ABBV Stock Holding History

EAGLE HARBOR ASSET MANAGEMENT INC /ADV’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$614K	Hold	2,441	–	–	0.48%	60
2026 Q1	$531K	Sell	2,441 -422	-15%	-$93.6K	0.45%	70
2025 Q4	$654K	Sell	2,863 -127	-4%	-$28.9K	0.54%	55
2025 Q3	$692K	Hold	2,990	–	–	0.6%	52
2025 Q2	$555K	Hold	2,990	–	–	0.54%	60
2025 Q1	$626K	Sell	2,990 -133	-4%	-$25.9K	0.64%	53
2024 Q4	$555K	Hold	3,123	–	–	0.56%	56
2024 Q3	$617K	Hold	3,123	–	–	0.61%	51
2024 Q2	$536K	Hold	3,123	–	–	0.57%	58
2024 Q1	$569K	Sell	3,123 -682	-18%	-$118K	0.6%	55
2023 Q4	$590K	Sell	3,805 -51	-1%	-$7.43K	0.68%	49
2023 Q3	$575K	Sell	3,856 -398	-9%	-$58.4K	0.75%	40
2023 Q2	$573K	Sell	4,254 -800	-16%	-$117K	0.75%	44
2023 Q1	$805K	Sell	5,054 -443	-8%	-$67.7K	1.09%	27
2022 Q4	$888K	Sell	5,497 -2,009	-27%	-$308K	1.3%	24
2022 Q3	$1.01M	Sell	7,506 -1,578	-17%	-$226K	1.73%	15
2022 Q2	$1.39M	Buy	9,084 +137	+2%	+$20.9K	2.15%	9
2022 Q1	$1.45M	Sell	8,947 -200	-2%	-$29.1K	1.88%	11
2021 Q4	$1.24M	Buy	+9,147	New	+$1.08M	1.63%	11

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

EAGLE HARBOR ASSET MANAGEMENT INC /ADV's ABBV Position: Q2 2026 in Review

EAGLE HARBOR ASSET MANAGEMENT INC /ADV held its AbbVie (ABBV) position steady in Q2 2026 at 2,441 shares worth $614K. The position accounts for 0.48% of the portfolio, ranked #60.

EAGLE HARBOR ASSET MANAGEMENT INC /ADV first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.45M in Q1 2022. 3,624 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

EAGLE HARBOR ASSET MANAGEMENT INC /ADV held 2,441 shares of AbbVie worth $614K as of Q2 2026.
EAGLE HARBOR ASSET MANAGEMENT INC /ADV left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.48% of EAGLE HARBOR ASSET MANAGEMENT INC /ADV's portfolio in Q2 2026, its #60 holding.
EAGLE HARBOR ASSET MANAGEMENT INC /ADV first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
EAGLE HARBOR ASSET MANAGEMENT INC /ADV's AbbVie position peaked at $1.45M in Q1 2022.
3,624 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on EAGLE HARBOR ASSET MANAGEMENT INC /ADV's 13F filing for Q2 2026, filed 11 Aug 2026.